DNA damage signaling in the cellular responses to mustard vesicants.


Journal

Toxicology letters
ISSN: 1879-3169
Titre abrégé: Toxicol Lett
Pays: Netherlands
ID NLM: 7709027

Informations de publication

Date de publication:
15 Jun 2020
Historique:
received: 09 12 2019
revised: 11 03 2020
accepted: 11 03 2020
pubmed: 17 3 2020
medline: 14 4 2020
entrez: 17 3 2020
Statut: ppublish

Résumé

Mustard vesicants, including sulfur mustard (2,2'-dichlorodiethyl sulfide, SM) and nitrogen mustard (bis(2-chloroethyl)methylamine, HN2) are cytotoxic blistering agents synthesized for chemical warfare. Because they contain highly reactive electrophilic chloroethyl side chains, they readily react with cellular macromolecules like DNA forming monofunctional and bifunctional adducts. By targeting DNA, mustards can compromise genomic integrity, disrupt the cell cycle, and cause mutations and cytotoxicity. To protect against genotoxicity following exposure to mustards, cells initiate a DNA damage response (DDR). This involves activation of signaling cascades including ATM (ataxia telangiectasia mutated), ATR (ataxia telangiectasia and Rad3-related) and DNA-PKcs (DNA-dependent protein kinase, catalytic unit). Signaling induced by the DDR leads to the recruitment and activation of repair related proteins such as phospho H2AX and phospho p53 to sites of DNA lesions. Excessive DNA modifications by mustards can overwhelm DNA repair leading to single and double strand DNA breaks, cytotoxicity and tissue damage, sometimes leading to cancer. Herein we summarize DDR signaling pathways induced by SM, HN2 and the half mustard, 2-chloroethyl ethyl sulfide (CEES). At the present time, little is known about how mustard-induced DNA damage leads to the activation of DDR signaling. A better understanding of mechanisms by which mustard vesicants induce the DDR may lead to the development of countermeasures effective in mitigating tissue injury.

Identifiants

pubmed: 32173488
pii: S0378-4274(20)30086-2
doi: 10.1016/j.toxlet.2020.03.008
pmc: PMC7224631
mid: NIHMS1578637
pii:
doi:

Substances chimiques

Mechlorethamine 50D9XSG0VR
Mustard Gas T8KEC9FH9P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-82

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES005022
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES004738
Pays : United States
Organisme : NIAMS NIH HHS
ID : U54 AR055073
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Toxicol Lett. 2012 Feb 25;209(1):1-10
pubmed: 22119920
Org Biomol Chem. 2012 Nov 28;10(44):8786-93
pubmed: 23070251
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a000745
pubmed: 20980439
Arch Toxicol. 2019 Jan;93(1):61-79
pubmed: 30324314
Chem Res Toxicol. 2004 Jul;17(7):950-62
pubmed: 15257621
Int J Biochem Cell Biol. 2017 Feb;83:1-14
pubmed: 27939754
Exp Mol Pathol. 2014 Jun;96(3):316-27
pubmed: 24662110
Toxicol Lett. 2015 Jun 15;235(3):161-71
pubmed: 25891025
PLoS One. 2016 Jul 21;11(7):e0159344
pubmed: 27442013
Mutat Res. 2014 May-Jun;763-764:53-63
pubmed: 24732344
Mol Cell. 2013 Mar 7;49(5):872-83
pubmed: 23333306
Environ Toxicol Pharmacol. 2017 Oct;55:68-73
pubmed: 28830012
Chem Res Toxicol. 1994 Mar-Apr;7(2):199-204
pubmed: 8199309
DNA Repair (Amst). 2009 Mar 1;8(3):400-12
pubmed: 19162564
Methods Enzymol. 2017;591:97-118
pubmed: 28645381
Toxicol Appl Pharmacol. 2016 Aug 15;305:267-273
pubmed: 27342729
Eur J Med Chem. 2018 May 10;151:401-433
pubmed: 29649739
Cornea. 2016 Feb;35(2):257-66
pubmed: 26555588
J Appl Toxicol. 2006 Sep-Oct;26(5):452-7
pubmed: 16906506
Nucleic Acids Res. 2011 Sep 1;39(17):7455-64
pubmed: 21666254
Chem Res Toxicol. 2019 Jun 17;32(6):1123-1133
pubmed: 30964658
Cell Cycle. 2018;17(11):1358-1371
pubmed: 29963960
Chem Res Toxicol. 2010 Jun 21;23(6):1034-44
pubmed: 20469912
Nat Rev Mol Cell Biol. 2008 Apr;9(4):297-308
pubmed: 18285803
Nucleic Acids Res. 2016 Sep 6;44(15):7281-91
pubmed: 27257072
Apoptosis. 2006 Sep;11(9):1545-59
pubmed: 16738803
EMBO J. 2019 Sep 16;38(18):e101801
pubmed: 31393028
Toxicology. 2009 Mar 29;257(3):105-12
pubmed: 19111594
Chem Biol Interact. 2015 Jul 25;237:31-7
pubmed: 25986970
Pharmacol Rev. 1996 Jun;48(2):289-326
pubmed: 8804107
Toxicol Lett. 2015 Jan 22;232(2):413-21
pubmed: 25448276
Toxicol Appl Pharmacol. 2010 Dec 1;249(2):178-87
pubmed: 20840853
Cold Spring Harb Perspect Biol. 2013 Aug 01;5(8):a012724
pubmed: 23813586
Environ Toxicol Pharmacol. 2018 Mar;58:230-236
pubmed: 29428683
J Biol Chem. 2018 Jul 6;293(27):10502-10511
pubmed: 29414795
Mutat Res. 1993 Oct;294(3):235-45
pubmed: 7692263
Environ Mol Mutagen. 2017 Jun;58(5):235-263
pubmed: 28485537
DNA Repair (Amst). 2019 Sep;81:102645
pubmed: 31307926
Cold Spring Harb Perspect Med. 2016 May 02;6(5):
pubmed: 27048304
Free Radic Biol Med. 2017 Jun;107:228-244
pubmed: 27890643
Chem Res Toxicol. 2014 Apr 21;27(4):490-500
pubmed: 24467472
Cell Cycle. 2005 Feb;4(2):339-45
pubmed: 15655354
Toxicol Lett. 2010 Aug 1;197(1):12-8
pubmed: 20435105

Auteurs

Yi-Hua Jan (YH)

Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ, 08854, United States.

Diane E Heck (DE)

Department of Environmental Health Science, New York Medical College, Valhalla, NY, 10595, United States.

Debra L Laskin (DL)

Department of Pharmacology and Toxicology, Rutgers University, Ernest Mario School of Pharmacy, Piscataway, NJ 08854, United States.

Jeffrey D Laskin (JD)

Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ, 08854, United States. Electronic address: jlaskin@eohsi.rutgers.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH